IRS1 (Insulin Receptor Substrate 1)

News alerts, weekly reports and conference planners

Entrez ID:

FAT1 mutation + FAT1 underexpression + IRS1 overexpression	Squamous Cell Carcinoma of Head and Neck	FAT1 mutation + FAT1 underexpression + IRS1 overexpression	Squamous Cell Carcinoma of Head and Neck	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3
FAT1 mutation + FAT1 underexpression + IRS1 overexpression	Squamous Cell Carcinoma of Head and Neck	FAT1 mutation + FAT1 underexpression + IRS1 overexpression	Squamous Cell Carcinoma of Head and Neck	EGFR inhibitor Resistant: C3 – Early Trials EGFR inhibitor Resistant : C3	EGFR inhibitor Resistant: C3 – Early Trials EGFR inhibitor Resistant : C3
IRS1-L	HER2 Negative Breast Cancer	IRS1-L	HER2 Negative Breast Cancer	AMG 479 Sensitive: C3 – Early Trials AMG 479 Sensitive : C3	AMG 479 Sensitive: C3 – Early Trials AMG 479 Sensitive : C3

Associations(3)